Submitted by Lorenzo.Piemonte on Wed, 09/14/2016 - 11:42
Living successfully with type 1 or type 2 diabetes requires the very large task of managing a serious chronic condition. The tasks associated with diabetes can be complex and demanding and most people in their life journey with diabetes report great frustration with the burden of the disease.
Submitted by Lorenzo.Piemonte on Wed, 09/14/2016 - 11:36
Type 1 diabetes is a relentless 24-7 condition to manage. With access to better technology and high volumes of data many people with diabetes are becoming data rich. However, access to device data and analyses are restricted by the diabetes device providers and the wider healthcare industry.
Submitted by Lorenzo.Piemonte on Tue, 05/31/2016 - 11:56
School is a vital part of life for children, who spend up to a third of their time in varying educational institutions from the age of 4 to 5 years through to young adulthood.
Submitted by aabolina on Fri, 03/11/2016 - 12:58
This World Tuberculosis (TB) Day, March 24 2016, the World Health Organization (WHO) is calling for renewed commitments and action in the global fight against TB – one of the world’s top infectious killers. While effective diagnosis and treatment of TB saved an estimated 43 million lives between 2000 and 2014, TB remains one of the world’s biggest threats, with 1.5 million people killed by the disease every year.
Submitted by Lorenzo.Piemonte on Tue, 09/01/2015 - 11:09
Hypoglycaemia in diabetes is often considered to be relevant only to those with type 1 diabetes T1D. Evidence has long been available that hypoglycaemia occurs in people with type 2 diabetes (T2D) using sulphonylureas.
Submitted by Lorenzo.Piemonte on Wed, 07/01/2015 - 14:00
Did you know that every 20 seconds an amputation caused by diabetes occurs somewhere in the world? Paradoxically 85 percent of all amputations caused by diabetes are preventable. If amputation is almost always preventable then this is good news for people at greatest risk for diabetic foot disease. Sadly, amputations are still occurring at too great a rate in high, low- and middle-income countries.
Submitted by Lorenzo.Piemonte on Wed, 07/01/2015 - 13:50
It was 32ºC in the Capital city of Santo Domingo in the Dominican Republic on the day I met Jeffrey, who at 28 had lived with diabetes for 14 years. It was so hot at the Plaza de la Salud General Hospital that volunteers were giving bottles of water to visitors at the front entrance. Jeffrey and I had never met when he appeared in my office and I did not know why he had come for a consultation. He was wet with sweat from the heat outside and I noticed he was not wearing shoes.
Submitted by Lorenzo.Piemonte on Tue, 03/03/2015 - 11:05
La monitorización continua de glucosa (MCG) es una tecnología relativamente nueva que tiene el potencial de ayudar a las personas que viven con diabetes tipo 1 o tipo 2 y son tratadas con insulina a lograr el objetivo de control óptimo de la glucemia.
Submitted by Lorenzo.Piemonte on Tue, 03/03/2015 - 11:00
La surveillance continue de la glycémie (SCG) est une technologie relativement nouvelle qui pourrait aider les personnes atteintes de diabète de type 1 ou de type 2 sous insuline à atteindre l'objectif d'un contrôle optimal de leur glycémie.
Submitted by Lorenzo.Piemonte on Mon, 03/02/2015 - 17:02
Controlar la diabetes tipo 1 y la diabetes tipo 2 lleva mucho tiempo, es complejo y, con frecuencia, difícil. Frecuentemente se detectan síntomas de agotamiento debido al control diabético, ya que muchas personas se sienten a la vez sobrepasadas y vencidas por la diabetes, además de frustradas por la carga que supone el autocontrol diabético.